Target intelligence / Profile preview

Immunoglobulin E specific for bluefish parvalbumin (Bluefish parvalbumin-specific IgE)

Target
Bluefish parvalbumin-specific IgE
Molecular classification
Antibody, Immunoglobulin, Glycoprotein
01

Overview

Immunoglobulin E (IgE) specific for bluefish parvalbumin is a specialized antibody that mediates allergic reactions to the bluefish (Pomatomus saltatrix). The primary allergen involved is parvalbumin, a calcium-binding protein found in fish muscle tissue, which is designated as Pom s 1 in this species (WHO/IUIS Allergen Nomenclature). In sensitized individuals, these specific IgE antibodies are produced by B cells and reside on the surface of mast cells and basophils via the high-affinity FceRI receptor. Upon ingestion or inhalation of bluefish proteins, the allergen cross-links the IgE-FceRI complexes, triggering the rapid degranulation and release of inflammatory mediators like histamine and leukotrienes (StatPearls, 2023). This biological cascade results in clinical symptoms of fish allergy, ranging from mild urticaria to life-threatening anaphylaxis. While therapeutic agents like omalizumab target the constant region of all IgE molecules to neutralize them, specific IgE levels are primarily utilized as diagnostic biomarkers to assess sensitization and the risk of severe reactions (PubMed, PMID: 26022875). Understanding the cross-reactivity between bluefish parvalbumin and other fish parvalbumins is essential for the clinical management of polysensitized patients.

Other names
Anti-bluefish parvalbumin IgEPom s 1-specific IgEBluefish-specific IgEIgE specific for Pomatomus saltatrix allergens
02

Mechanism of action

Anti-IgE monoclonal antibodies bind to the C-epsilon-3 (Ce3) domain of free circulating IgE, preventing it from binding to the high-affinity IgE receptor (FceRI) on mast cells and basophils, thereby inhibiting the release of inflammatory mediators.

03

Biological functions

Immune responseType I hypersensitivityMast cell degranulationBasophil activationAllergen binding
04

Disease associations

Fish allergyFood allergyAnaphylaxisUrticariaAngioedema
05

Safety considerations

Risk of systemic anaphylaxis during allergen-specific immunotherapyPotential for injection site reactions with anti-IgE biologicsTheoretical risk of increased susceptibility to helminth infectionsRisk of malignancy (though data for anti-IgE is generally reassuring)
06

Interacting drugs

Omalizumab

2 more in the full profile.

07

Biomarkers

Serum specific IgE (sIgE) levelsSkin prick test (SPT) reactivityBasophil activation test (BAT)Total serum IgE

Beyond the preview

Go deeper on Immunoglobulin E specific for bluefish parvalbumin (Bluefish parvalbumin-specific IgE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Immunoglobulin E specific for bluefish parvalbumin (Bluefish parvalbumin-specific IgE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call